FDA Announces Rare Disease Framework Initiative, Invites Input on Potential Regulatory Changes

At the October 28 public meeting, held with the Reagan-Udall Foundation for the FDA on these issues, agency leaders emphasized transformational rather than incremental change, with one panelist calling for a “quantum leap.”